Resolute Integrity zotarolimus-Eluting Coronary Stent Systems
FDA premarket approval P110013/S108 · decided 2021-03-12
Approval details
- PMA number
- P110013
- Supplement
- S108
- Supplement type
- 30-Day Notice
- Supplement reason
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
- Trade name
- Resolute Integrity zotarolimus-Eluting Coronary Stent Systems
- Generic name
- Coronary drug-eluting stent
- Applicant
- Medtronic Vascular
- Date received
- 2021-03-04
- Decision date
- 2021-03-12
- Days to decision
- 8 days
- Decision code
- OK30
- Product code
- NIQ
- Advisory committee
- Cardiovascular
- Expedited review
- No
- Location
- Santa Rosa, CA
- Statement
- Implementation of new product label and component verification software for use on manufacturing lines in Medtronic Ireland.
Class III intelligence, same tools
PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.